LaRosa, Nicholas R. – Trademark Portfolio

Entity Type: 01

LaRosa, Nicholas R. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MONEYFADE. The owner is based in Chesterfield, MI.

33888 Michigamme Dr.

Chesterfield, MI 48047

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LaRosa, Nicholas R.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does LaRosa, Nicholas R. have?

LaRosa, Nicholas R. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does LaRosa, Nicholas R. file in?

LaRosa, Nicholas R. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are LaRosa, Nicholas R.'s most well-known trademarks?

LaRosa, Nicholas R.'s registered trademark portfolio includes well-known marks such as MONEYFADE. These are among 2 currently registered trademarks in the portfolio.

What is LaRosa, Nicholas R.'s trademark registration success rate?

LaRosa, Nicholas R. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.